Bid Publish Date
28-Dec-2024, 2:03 pm
Bid End Date
27-Jan-2025, 2:00 pm
Value
₹4,50,000
Location
Progress
Quantity
5960
Employees State Insurance Corporation has released a public tender for Polymer HRP, Immunowash Buffer, Pap Pen Hydrophobic pen, ER, PR, Her2obliqueNeu, Ki67, Napsin A, P forty, P sixty three, CK twenty, PAN CK, LMWK, HMWK, MSH six, HMB forty five, Melan A, GATA three, TRPS 1, Betacatenin, Myogenin, SMA, Desmin, Synaptophysin, Chromogranin A, Calretinin, Inhibin, CD38, CD 138, DOG 1, P16, Glycophorin, EMA, CD 10, CD 15, CD 20, CD 23, CD 30, CD 31, CD 43, PAX 2, TdT, PTEN, BCL 2, NKX 2point2, SALL 4, CDX 2, BOB, Positively charged slides for IHC, WT 1, BCOR, INI 1, CD3, MUM1, Cryogel for cryostat, Antigen Retreival citrate Buffer, Antigen Retreival Buffer TRIS EDTA in WEST DELHI, DELHI. Quantity: 5960. Submission Deadline: 27-01-2025 14: 00: 00. Download documents and apply online.
Tender Category
Goods
Bid To RA
No
Item Category
Polymer HRP , Immunowash Buffer , Pap Pen Hydrophobic pen , ER , PR , Her2obliqueNeu , Ki67 , Napsin A , P forty , P sixty three , CK twenty , PAN CK , LMWK , HMWK , MSH six , HMB forty five , Melan A , GATA three , TRPS 1 , Betacatenin , Myogenin , SMA , Desmin , Synaptophysin , Chromogranin A , Calretinin , Inhibin , CD38 , CD 138 , DOG 1 , P16 , Glycophorin , EMA , CD 10 , CD 15 , CD 20 , CD 23 , CD 30 , CD 31 , CD 43 , PAX 2 , TdT , PTEN , BCL 2 , NKX 2point2 , SALL 4 , CDX 2 , BOB , Positively charged slides for IHC , WT 1 , BCOR , INI 1 , CD3 , MUM1 , Cryogel for cryostat , Antigen Retreival citrate Buffer , Antigen Retreival Buffer TRIS EDTA
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Polymer HRP
Polymer HRP Universal immunochemistry detection kit for 1000 tests
Immunowash Buffer
Immunowash Buffer 25x Pack size 500 ml
Pap Pen Hydrophobic pen
Pap Pen Hydrophobic pen
ER
ER SP1 EP1
PR
PR SP2orPgR1294or16or PgR636
Her2obliqueNeu
Her2 Neu ERBB2 SP3 CB11
Ki67
Ki67 MIB1 SP6
Napsin A
Napsin A IP64 EP205 MRQ 60 BC15
P forty
P40 BC 28 or Z R8 or DAKP 40
P sixty three
P 63 4A4 or DAK p63
CK twenty
CK 20 SP 33 or Ks 20.8
PAN CK
PAN CK AE 1 or AE 3
LMWK
LMWK CAM 5point2
HMWK
HMWK 34 beta E 12
MSH six
MSH 6 SP 93 or EP 49
HMB forty five
HMB 45
Melan A
Melan A A 03 MART 1
GATA three
GATA3 L 50 823
TRPS 1
TRPS 1 ZR3 82
Betacatenin
Betacatenin IVD RTU
Myogenin
Myogenin
SMA
SMA BS66 or EP 188 or 1A4
Desmin
Desmin DE R 11 or D 33
Synaptophysin
Synaptophysin SP 11 or MRQ 40 or 27 G 12 or DAK SYNAP or BS 15
Chromogranin A
Chromogranin A LK 2H 10
Calretinin
Calretinin
Inhibin
Inhibin
CD38
CD38
CD 138
CD 138 B A 38 or EP 201 or MI 15
DOG 1
DOG 1 K9 or SP 31 or DOG 1.1
P16
P 16 E 6 H 4 or JC 2 or 6 H 12 or MX 007
Glycophorin
Glycophorin
EMA
EMA E29
CD 10
CD 10 SP 67 or 56 C 6 or DAK CD TEN
CD 15
CD 15 MMA
CD 20
CD 20 L26
CD 23
CD 23 SP 23 or DAK 23 or 1 B 12 or BS 20
CD 30
CD 30 Ber H2
CD 31
CD 31 JC70A
CD 43
CD 43
PAX 2
PAX 2
TdT
TdT SEN28 or EP266
PTEN
PTEN
BCL 2
BCL TWO 100 or D5 or SP66 or 124
NKX 2point2
NKX 2.2
SALL 4
SALL 4 6E3
CDX 2
CDX 2 EPR2764Y or EP25 or DAK CDX2
BOB
BOB 1
Positively charged slides for IHC
Positively charged slides for IHC
WT 1
WT 1 EP122 or 6FH2 or WT49
BCOR
BCOR
INI 1
INI 1
CD3
CD3 F7.2.38 LN10 PS1 ZM45 2GV6 SP7 MRQ39 EP41 EP177
MUM1
MUM1 MUM1p EAU32 EP190 BC5 MRQ43
Cryogel for cryostat
Cryogel for cryostat
Antigen Retreival citrate Buffer
Antigen Retreival citrate Buffer pH6.0 50X
Antigen Retreival Buffer TRIS EDTA
Antigen Retreival Buffer TRIS EDTA Ph 9.050X
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Polymer HRP | Polymer HRP Universal immunochemistry detection kit for 1000 tests | 2 | nos | bo-labdivision | 30 | |
| 2 | Immunowash Buffer | Immunowash Buffer 25x Pack size 500 ml | 2 | nos | bo-labdivision | 30 | |
| 3 | Pap Pen Hydrophobic pen | Pap Pen Hydrophobic pen | 2 | nos | bo-labdivision | 30 | |
| 4 | ER | ER SP1 EP1 | 12 | ml | bo-labdivision | 30 | |
| 5 | PR | PR SP2orPgR1294or16or PgR636 | 12 | ml | bo-labdivision | 30 | |
| 6 | Her2obliqueNeu | Her2 Neu ERBB2 SP3 CB11 | 12 | ml | bo-labdivision | 30 | |
| 7 | Ki67 | Ki67 MIB1 SP6 | 12 | ml | bo-labdivision | 30 | |
| 8 | Napsin A | Napsin A IP64 EP205 MRQ 60 BC15 | 12 | ml | bo-labdivision | 30 | |
| 9 | P forty | P40 BC 28 or Z R8 or DAKP 40 | 12 | ml | bo-labdivision | 30 | |
| 10 | P sixty three | P 63 4A4 or DAK p63 | 12 | ml | bo-labdivision | 30 | |
| 11 | CK twenty | CK 20 SP 33 or Ks 20.8 | 6 | ml | bo-labdivision | 30 | |
| 12 | PAN CK | PAN CK AE 1 or AE 3 | 6 | ml | bo-labdivision | 30 | |
| 13 | LMWK | LMWK CAM 5point2 | 6 | ml | bo-labdivision | 30 | |
| 14 | HMWK | HMWK 34 beta E 12 | 6 | ml | bo-labdivision | 30 | |
| 15 | MSH six | MSH 6 SP 93 or EP 49 | 6 | ml | bo-labdivision | 30 | |
| 16 | HMB forty five | HMB 45 | 6 | ml | bo-labdivision | 30 | |
| 17 | Melan A | Melan A A 03 MART 1 | 6 | ml | bo-labdivision | 30 | |
| 18 | GATA three | GATA3 L 50 823 | 6 | ml | bo-labdivision | 30 | |
| 19 | TRPS 1 | TRPS 1 ZR3 82 | 14 | ml | bo-labdivision | 30 | |
| 20 | Betacatenin | Betacatenin IVD RTU | 6 | ml | bo-labdivision | 30 | |
| 21 | Myogenin | Myogenin | 6 | ml | bo-labdivision | 30 | |
| 22 | SMA | SMA BS66 or EP 188 or 1A4 | 6 | ml | bo-labdivision | 30 | |
| 23 | Desmin | Desmin DE R 11 or D 33 | 6 | ml | bo-labdivision | 30 | |
| 24 | Synaptophysin | Synaptophysin SP 11 or MRQ 40 or 27 G 12 or DAK SYNAP or BS 15 | 6 | ml | bo-labdivision | 30 | |
| 25 | Chromogranin A | Chromogranin A LK 2H 10 | 6 | ml | bo-labdivision | 30 | |
| 26 | Calretinin | Calretinin | 6 | ml | bo-labdivision | 30 | |
| 27 | Inhibin | Inhibin | 6 | ml | bo-labdivision | 30 | |
| 28 | CD38 | CD38 | 6 | ml | bo-labdivision | 30 | |
| 29 | CD 138 | CD 138 B A 38 or EP 201 or MI 15 | 6 | ml | bo-labdivision | 30 | |
| 30 | DOG 1 | DOG 1 K9 or SP 31 or DOG 1.1 | 6 | ml | bo-labdivision | 30 | |
| 31 | P16 | P 16 E 6 H 4 or JC 2 or 6 H 12 or MX 007 | 6 | ml | bo-labdivision | 30 | |
| 32 | Glycophorin | Glycophorin | 6 | ml | bo-labdivision | 30 | |
| 33 | EMA | EMA E29 | 6 | ml | bo-labdivision | 30 | |
| 34 | CD 10 | CD 10 SP 67 or 56 C 6 or DAK CD TEN | 6 | ml | bo-labdivision | 30 | |
| 35 | CD 15 | CD 15 MMA | 6 | ml | bo-labdivision | 30 | |
| 36 | CD 20 | CD 20 L26 | 6 | ml | bo-labdivision | 30 | |
| 37 | CD 23 | CD 23 SP 23 or DAK 23 or 1 B 12 or BS 20 | 6 | ml | bo-labdivision | 30 | |
| 38 | CD 30 | CD 30 Ber H2 | 6 | ml | bo-labdivision | 30 | |
| 39 | CD 31 | CD 31 JC70A | 6 | ml | bo-labdivision | 30 | |
| 40 | CD 43 | CD 43 | 6 | ml | bo-labdivision | 30 | |
| 41 | PAX 2 | PAX 2 | 6 | ml | bo-labdivision | 30 | |
| 42 | TdT | TdT SEN28 or EP266 | 6 | ml | bo-labdivision | 30 | |
| 43 | PTEN | PTEN | 6 | ml | bo-labdivision | 30 | |
| 44 | BCL 2 | BCL TWO 100 or D5 or SP66 or 124 | 6 | ml | bo-labdivision | 30 | |
| 45 | NKX 2point2 | NKX 2.2 | 6 | ml | bo-labdivision | 30 | |
| 46 | SALL 4 | SALL 4 6E3 | 6 | ml | bo-labdivision | 30 | |
| 47 | CDX 2 | CDX 2 EPR2764Y or EP25 or DAK CDX2 | 6 | ml | bo-labdivision | 30 | |
| 48 | BOB | BOB 1 | 6 | ml | bo-labdivision | 30 | |
| 49 | Positively charged slides for IHC | Positively charged slides for IHC | 3,600 | nos | bo-labdivision | 30 | |
| 50 | WT 1 | WT 1 EP122 or 6FH2 or WT49 | 6 | ml | bo-labdivision | 30 | |
| 51 | BCOR | BCOR | 6 | ml | bo-labdivision | 30 | |
| 52 | INI 1 | INI 1 | 6 | ml | bo-labdivision | 30 | |
| 53 | CD3 | CD3 F7.2.38 LN10 PS1 ZM45 2GV6 SP7 MRQ39 EP41 EP177 | 6 | ml | bo-labdivision | 30 | |
| 54 | MUM1 | MUM1 MUM1p EAU32 EP190 BC5 MRQ43 | 6 | ml | bo-labdivision | 30 | |
| 55 | Cryogel for cryostat | Cryogel for cryostat | 4 | nos | bo-labdivision | 30 | |
| 56 | Antigen Retreival citrate Buffer | Antigen Retreival citrate Buffer pH6.0 50X | 1,000 | ml | bo-labdivision | 30 | |
| 57 | Antigen Retreival Buffer TRIS EDTA | Antigen Retreival Buffer TRIS EDTA Ph 9.050X | 1,000 | ml | bo-labdivision | 30 |
Discover companies most likely to bid on this tender
Key insights about DELHI tender market
The eligibility requirements include being a registered entity, possessing the necessary certifications compliant with the standards of diagnostic laboratory supplies, and registration with the Government e-Marketplace (GeM). Bidders should prove their capacity to deliver the items specified in the tender scope effectively.
Bidders must provide relevant product certifications that showcase compliance with industry standards for Immuno Histochemistry lab kits. This includes CE marking, ISO certifications, and specific validation reports for reagents and diagnostic materials.
The registration process involves creating an account on the GeM portal, completing all necessary profile information, and submitting documentation that verifies eligibility and compliance. It is advisable to do this well in advance to avoid last-minute issues.
Submission documents must be provided in standard formats, typically PDF or DOCX, as specified in the GeM portal guidelines. All documents must be submitted electronically with attention to file size limits and format compatibility.
Yes, the technical specifications require that all items must meet the diagnostic efficacy as per the guidelines provided in the tender, including specifics about the types of antibodies and buffers needed for immunohistochemistry.
Products must adhere to the quality standards established for Immuno Histochemistry lab kits, which include regulatory compliance such as CE marking and adherence to international quality benchmarks to ensure safety and efficacy.
Bidders must ensure compliance with all applicable regulations and guidelines pertaining to diagnostic supplies. This includes adherence to safety standards, documentation of quality control processes, and environmental compliance where relevant.
The Earnest Money Deposit (EMD) typically is a part of the submission process to ensure commitment from bidders. The EMD amount will be specified in the tender documents and is expected to be submitted before the closing of the bidding.
Once awarded the contract, winners may need to provide performance security, ensuring fulfillment of the contract stipulations. The details regarding the exact percentage and conditions would be outlined in the tender documents.
Payment terms typically involve initial payments upon delivery acceptance, with the remaining balance settled after successful confirmation of product efficiency and delivery as required under the contract agreement.
The price evaluation considerations will use a total value-wise evaluation approach, meaning all costs will be tallied against the value and quality presented in the bids, taking into consideration competitive pricing and compliance.
Key timelines, including submission deadlines and dates for bid openings, are detailed in the tender documents. It is essential to adhere strictly to these timelines to ensure participation.
Notification of results will be made available through official channels on the GeM platform following the completion of the evaluation and selection process, ensuring transparency in the announcement of successful bidders.
MSEs may receive benefits such as exemptions from certain eligibility criteria, reduced requirement for EMD, and other promotional advantages that encourage participation from smaller enterprises in government procurement.
Yes, startups may have access to relaxed eligibility criteria and benefits aimed at encouraging innovation and participation in government contracts, specifically designed to aid nascent companies in competing effectively.
This tender aligns with the 'Make in India' initiative by prioritizing local manufacturing and encouraging the procurement of domestically produced products, fostering a supportive environment for local suppliers and manufacturers.
Bidders are expected to comply with local content requirements as outlined by government procurement policies, which necessitate a specified percentage of local content in the products to promote the domestic manufacturing ecosystem.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS